✕
Login
Register
Back to News
HC Wainwright & Co. Maintains Buy on Cogent Biosciences, Raises Price Target to $55
Benzinga Newsdesk
www.benzinga.com
Positive 84.6%
Neg 0%
Neu 0%
Pos 84.6%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment